{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T03:04:19Z","timestamp":1788577459927,"version":"build-2803163510"},"reference-count":102,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,12]],"date-time":"2020-10-12T00:00:00Z","timestamp":1602460800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,12]],"date-time":"2020-10-12T00:00:00Z","timestamp":1602460800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rev Endocr Metab Disord"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1007\/s11154-020-09602-4","type":"journal-article","created":{"date-parts":[[2020,10,12]],"date-time":"2020-10-12T19:10:54Z","timestamp":1602529854000},"page":"59-70","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Insights from the clinical phenotype of subjects with Laron syndrome in Ecuador"],"prefix":"10.1007","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9298-6484","authenticated-orcid":false,"given":"Jaime","family":"Guevara-Aguirre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camila","family":"Bautista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Pe\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Guevara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Palacios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Guevara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio W. D.","family":"Gavilanes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,12]]},"reference":[{"issue":"2","key":"9602_CR1","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1093\/ajcn.81.2.341","volume":"81","author":"L Cordain","year":"2005","unstructured":"Cordain L, Eaton SB, Sebastian A, Mann N, Lindeberg S, Watkins BA, et al. Origins and evolution of the western diet: health implications for the 21st century. Am J Clin Nutr. 2005;81(2):341\u201354.","journal-title":"Am J Clin Nutr"},{"issue":"2","key":"9602_CR2","first-page":"417","volume":"76","author":"J Guevara-Aguirre","year":"1993","unstructured":"Guevara-Aguirre J, Rosenbloom A, Fielder P, Diamond FJ, Rosenfeld R. Growth hormone receptor deficiency in Ecuador: clinical and biochemical phenotype in two populations. J Clin Endocrinol Metab. 1993;76(2):417\u201323.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"9602_CR3","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1210\/edrv-15-3-369","volume":"15","author":"EG Rosenfeld","year":"1994","unstructured":"Rosenfeld EG, Rosenbloom A, Guevara-Aguirre J. Growth hormone (GH) insensitivity due to primary GH receptor deficiency. Endocr Rev. 1994;15(3):369\u201390.","journal-title":"Endocr Rev"},{"issue":"1","key":"9602_CR4","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1002\/humu.1380010105","volume":"1","author":"MA Berg","year":"1992","unstructured":"Berg MA, Guevara-Aguirre J, Rosenbloom AL, Rosenfeld RG, Francke U. Mutation creating a new splice site in the growth hormone receptor genes of 37 Ecuadorian patients with Laron syndrome. Hum Mutat. 1992;1(1):24\u201332.","journal-title":"Hum Mutat"},{"issue":"2","key":"9602_CR5","first-page":"152","volume":"2","author":"Z Laron","year":"1966","unstructured":"Laron Z, Pertzelan A, Mannheimer S. Genetic pituitary dwarfism with high serum concentration of growth hormone. A new inborn error of metabolism? Isr J Med Sci. 1966;2(2):152\u20135.","journal-title":"Isr J Med Sci"},{"issue":"2","key":"9602_CR6","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s00439-011-1072-z","volume":"131","author":"C Velez","year":"2012","unstructured":"Velez C, Palamara PF, Guevara-Aguirre J, Hao L, Karafet T, Guevara-Aguirre M, et al. The impact of Converso Jews on the genomes of modern Latin Americans. Hum Genet. 2012;131(2):251\u201363.","journal-title":"Hum Genet"},{"issue":"20","key":"9602_CR7","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1056\/NEJM199011153232002","volume":"323","author":"A Rosenbloom","year":"1990","unstructured":"Rosenbloom A, Guevara-Aguirre J, Rosenfeld R, Fielder P. The little women of Loja: growth hormone-receptor deficiency in an inbred population of southern Ecuador. N Engl J Med. 1990;323(20):1367\u201374.","journal-title":"N Engl J Med"},{"issue":"20","key":"9602_CR8","doi-asserted-by":"publisher","first-page":"8083","DOI":"10.1073\/pnas.86.20.8083","volume":"86","author":"PJ Godowski","year":"1989","unstructured":"Godowski PJ, Leung DW, Meacham LR, Galgani JP, Hellmiss R, Keret R, et al. Characterization of the human growth hormone receptor gene and demonstration of a partial gene deletion in two patients with Laron-type dwarfism. Proc Natl Acad Sci U S A. 1989;86(20):8083\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"389","key":"9602_CR9","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1651-2227.1993.tb12838.x","volume":"82","author":"PJ Fielder","year":"1993","unstructured":"Fielder PJ, Gargosky SE, Vaccarello M, Wilson K, Cohen K, Diamond F, et al. Serum profiles of insulin-like growth factors and their binding proteins in adults with growth hormone receptor deficiency treated with insulin-like growth factor I. Acta Paediatr Suppl. 1993;82(389):40\u20133.","journal-title":"Acta Paediatr Suppl"},{"issue":"6","key":"9602_CR10","first-page":"1683","volume":"77","author":"SE Gargosky","year":"1993","unstructured":"Gargosky SE, Wilson KF, Fielder PJ, Vaccarello MA, Guevara-Aguirre J, Diamond FB, et al. The composition and distribution of insulin-like growth factors (IGFs) and IGF-binding proteins (IGFBPs) in the serum of growth hormone receptor-deficient patients: effects of IGF-I therapy on IGFBP-3. J Clin Endocrinol Metab. 1993;77(6):1683\u20139.","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"9602_CR11","doi-asserted-by":"publisher","first-page":"5176","DOI":"10.1210\/jcem.86.11.8019","volume":"86","author":"CK Buckway","year":"2001","unstructured":"Buckway CK, Guevara-Aguirre J, Pratt KL, Burren CP, Rosenfeld RG. The IGF-I generation test revisited: a marker of GH sensitivity. J Clin Endocrinol Metab. 2001;86(11):5176\u201383.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"9602_CR12","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1172\/JCI112884","volume":"79","author":"NS Schwartz","year":"1987","unstructured":"Schwartz NS, Clutter WE, Shah SD, Cryer PE. Glycemic thresholds for activation of glucose counterregulatory systems are higher than the threshold for symptoms. J Clin Invest. 1987;79(3):777\u201381.","journal-title":"J Clin Invest"},{"issue":"1","key":"9602_CR13","first-page":"273","volume":"77","author":"MA Vaccarello","year":"1993","unstructured":"Vaccarello MA, Diamond FB Jr, Guevara-Aguirre J, Rosenbloom AL, Fielder PJ, Gargosky S, et al. Hormonal and metabolic effects and pharmacokinetics of recombinant insulin-like growth factor-I in growth hormone receptor deficiency\/Laron syndrome. J Clin Endocrinol Metab. 1993;77(1):273\u201380.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"9602_CR14","first-page":"762","volume":"75","author":"DR Counts","year":"1992","unstructured":"Counts DR, Gwirtsman H, Carlsson LM, Lesem M, Cutler GB Jr. The effect of anorexia nervosa and refeeding on GH-binding protein, the insulin-like growth factors (IGFs), and the IGF-binding proteins. J Clin Endocrinol Metab. 1992;75(3):762\u20137.","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"9602_CR15","first-page":"4118","volume":"84","author":"M Aguiar-Olivera","year":"1999","unstructured":"Aguiar-Olivera M, Gill M, Barretto E, Alc\u00e2ntara M, Miraki-Moud F, Menezes C, et al. Effect of severe GH deficiency due to a mutation in the GHRH receptor on IGFs, IGFBPs, and ternary complex formation throughout life. J Clin Endocrinol Metab. 1999;84(11):4118\u201326.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"9602_CR16","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1056\/NEJM199610313351810","volume":"335","author":"J Guevara-Aguirre","year":"1996","unstructured":"Guevara-Aguirre J. Insulin-like growth factor I - an important intrauterine growth factor. N Engl J Med. 1996;335(1):1389\u201391.","journal-title":"N Engl J Med"},{"issue":"6","key":"9602_CR17","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1136\/adc.68.6.768","volume":"68","author":"Z Laron","year":"1993","unstructured":"Laron Z, Lilos P, Klinger B. Growth curves for Laron syndrome. Arch Dis Child. 1993;68(6):768\u201370.","journal-title":"Arch Dis Child"},{"issue":"2","key":"9602_CR18","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1210\/jcem-73-2-428","volume":"73","author":"SR Rose","year":"1991","unstructured":"Rose SR, Municchi G, Barnes KM, Kamp GA, Uriarte MM, Ross JL, et al. Spontaneous growth hormone secretion increases during puberty in normal girls and boys. J Clin Endocrinol Metab. 1991;73(2):428\u201335.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"9602_CR19","first-page":"1393","volume":"80","author":"J Guevara-Aguirre","year":"1995","unstructured":"Guevara-Aguirre J, Vasconez O, Martinez V, Martinez AL, Rosenbloom AL, Diamond FB, et al. A randomized, double blind, placebo-controlled trial on safety and efficacy of recombinant human insulin-like growth factor-I in children with growth hormone receptor deficiency. J Clin Endocrinol Metab. 1995;80(4):1393\u20138.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"9602_CR20","first-page":"248","volume":"76","author":"H Crosnier","year":"1993","unstructured":"Crosnier H, Gourmelen M, Pr\u00e9vot C, Rappaport R. Effects of nutrient intake on growth, insulin-like growth factors, and their binding proteins in a Laron-type dwarf. J Clin Endocrinol Metab. 1993;76(1):248\u201350.","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"9602_CR21","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1136\/jmg.31.8.635","volume":"31","author":"GB Schaefer","year":"1994","unstructured":"Schaefer GB, Rosenbloom AL, Guevara-Aguirre J, Campbell EA, Ullrich F, Patil K, et al. Facial morphometry in Ecuadorian patients with GHRD\/Laron syndrome. J Med Genet. 1994;31(8):635\u20139.","journal-title":"J Med Genet"},{"issue":"3","key":"9602_CR22","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1359\/jbmr.1998.13.3.415","volume":"3","author":"LK Bachrach","year":"1998","unstructured":"Bachrach LK, Marcus R, Ott SM, Rosenbloom AL, Vasconez O, Martinez V, et al. Bone mineral, histomorphometry, and body composition in adults with growth hormone receptor deficiency. J Bone Miner Res. 1998;3(3):415\u201321.","journal-title":"J Bone Miner Res"},{"issue":"7","key":"9602_CR23","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/1043-2760(94)P3205-L","volume":"5","author":"AL Rosenbloom","year":"1994","unstructured":"Rosenbloom AL, Guevara-Aguirre J, Rosenfeld RG, Pollock BH. Growth in growth hormone insensitivity. Trends Endocrinol Metab. 1994;5(7):296\u2013303.","journal-title":"Trends Endocrinol Metab"},{"issue":"1","key":"9602_CR24","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1210\/jcem-59-1-34","volume":"59","author":"MA Rivarola","year":"1984","unstructured":"Rivarola MA, Phillips JA, Migeon CJ, Heinrich JJ, Hjelle BJ. Phenotypic heterogeneity in familial isolated growth hormone deficiency type I-A. J Clin Endocrinol Metab. 1984;59(1):34\u201340.","journal-title":"J Clin Endocrinol Metab"},{"key":"9602_CR25","unstructured":"Guevara-Aguirre J, De la Torre W, Rosenbloom AL, Acosta M, Rosenfeld RG. Osteopenia in menstruating women with low IGF-I levels due to growth hormone receptor deficiency. 73rd Annual Meeting of The Endocrine Society, Washington, DC. 1991."},{"issue":"7","key":"9602_CR26","doi-asserted-by":"publisher","first-page":"2589","DOI":"10.1210\/jc.2015-1678","volume":"100","author":"J Guevara-Aguirre","year":"2015","unstructured":"Guevara-Aguirre J, Rosenbloom AL, Balasubramanian P, Teran E, Guevara-Aguirre M, Guevara C, et al. GH receptor deficiency in Ecuadorian adults is associated with obesity and enhanced insulin sensitivity. J Clin Endocrinol Metab. 2015;100(7):2589\u201396.","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"9602_CR27","first-page":"3036","volume":"85","author":"N Mauras","year":"2000","unstructured":"Mauras N, Martinez V, Rini A, Guevara-Aguirre J. rhIGF-I has significant metabolic effects in adults with GH receptor deficiency: studies on protein, glucose and lipid metabolism. J Clin Endocrinol Metab. 2000;85(9):3036\u201342.","journal-title":"J Clin Endocrinol Metab"},{"key":"9602_CR28","volume-title":"Gavilanes A","author":"J Guevara-Aguirre","year":"2020","unstructured":"Guevara-Aguirre J, Teran E, Lescano D, Guevara C, Guevara A, Saavedra J, et al. Gavilanes A. GHIR: Assessing insulin sensitivity in syndromes of short stature; 2020. (in press)"},{"issue":"3","key":"9602_CR29","first-page":"25","volume":"64","author":"W Cutfield","year":"2005","unstructured":"Cutfield W, Hofman PL. Simple fasting methods to assess insulin sensitivity in childhood. Horm Res. 2005;64(3):25\u201331.","journal-title":"Horm Res"},{"issue":"9","key":"9602_CR30","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1093\/oxfordjournals.aje.a116768","volume":"137","author":"M Laakso","year":"1993","unstructured":"Laakso M. How good a marker is insulin level for insulin resistance? Am J Epidemiol. 1993;137(9):959\u201365.","journal-title":"Am J Epidemiol"},{"issue":"1","key":"9602_CR31","doi-asserted-by":"publisher","first-page":"160","DOI":"10.4103\/2230-8210.146874","volume":"19","author":"M Gutch","year":"2015","unstructured":"Gutch M, Kumar S, Razi SM, Gupta KK, Gupta A. Assessment of insulin sensitivity\/resistance. Indian J Endocrinol Metab. 2015;19(1):160\u20134.","journal-title":"Indian J Endocrinol Metab"},{"issue":"8","key":"9602_CR32","doi-asserted-by":"publisher","first-page":"3626","DOI":"10.1210\/jc.2003-030219","volume":"88","author":"P Ducluzeau","year":"2003","unstructured":"Ducluzeau P, Cousin P, Malvoisin E, Bornet H, Vidal H, Laville M, et al. Glucose-to-insulin ratio rather than sex hormone-binding globulin and adiponectin levels is the best predictor of insulin resistance in nonobese women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2003;88(8):3626\u201331.","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"9602_CR33","first-page":"2694","volume":"83","author":"RS Legro","year":"1998","unstructured":"Legro RS, Finegood D, Dunaif A. A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 1998;83(8):2694\u20138.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"9602_CR34","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/1756-0500-7-98","volume":"7","author":"DS Thompson","year":"2014","unstructured":"Thompson DS, Boyne MS, Osmond C, Ferguson TS, Tulloch-Reid M, Wilks RJ, et al. Limitations of fasting indices in the measurement of insulin sensitivity in Afro-Caribbean adults. BMC Res Notes. 2014;7(1):98.","journal-title":"BMC Res Notes"},{"issue":"5","key":"9602_CR35","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/sj.ijo.0800864","volume":"23","author":"A Avignon","year":"1999","unstructured":"Avignon A, Boegner C, Mariano-Goulart D, Colette C, Monnier L. Assessment of insulin sensitivity from plasma insulin and glucose in the fasting or post oral glucose-load state. Int J Obes Relat Metab Disord. 1999;23(5):512\u20137.","journal-title":"Int J Obes Relat Metab Disord"},{"issue":"2","key":"9602_CR36","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1006\/mgme.1997.2658","volume":"63","author":"F Belfiore","year":"1998","unstructured":"Belfiore F, Iannello S, Volpicelli G. Insulin sensitivity indices calculated from basal and OGTT-induced insulin, glucose, and FFA levels. Mol Gen Metab. 1998;63(2):134\u201341.","journal-title":"Mol Gen Metab"},{"issue":"3","key":"9602_CR37","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/S0168-8227(99)00116-3","volume":"47","author":"M Gutt","year":"2000","unstructured":"Gutt M, Davis CL, Spitzer SB, Llabre M, Kumar M, Czarnecki E, et al. Validation of the insulin sensitivity index (ISI0,120): comparison with other measures. Diabetes Res Clin Pract. 2000;47(3):177\u201384.","journal-title":"Diabetes Res Clin Pract"},{"issue":"7","key":"9602_CR38","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412\u20139.","journal-title":"Diabetologia."},{"issue":"70","key":"9602_CR39","doi-asserted-by":"publisher","first-page":"70ra13","DOI":"10.1126\/scitranslmed.3001845","volume":"3","author":"J Guevara-Aguirre","year":"2011","unstructured":"Guevara-Aguirre J, Balasubramanian P, Guevara-Aguirre M, Wei M, Madia F, Cheng C, et al. Growth Hormone Receptor Deficiency is associated with a major reduction in pro-aging signaling, cancer, and diabetes in humans. Sci Transl Med. 2011;3(70):70ra13.","journal-title":"Sci Transl Med"},{"issue":"9","key":"9602_CR40","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.2337\/diacare.22.9.1462","volume":"22","author":"M Matsuda","year":"1999","unstructured":"Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose. Tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care. 1999;22(9):1462\u201370.","journal-title":"Diabetes Care"},{"issue":"3","key":"9602_CR41","doi-asserted-by":"publisher","first-page":"460","DOI":"10.2337\/diacare.24.3.460","volume":"24","author":"KA McAuley","year":"2001","unstructured":"McAuley KA, Williams SM, Mann JI, Walker RJ, Lewis N, Temple L, et al. Diagnosing insulin resistance in the general population. Diabetes Care. 2001;24(3):460\u20134.","journal-title":"Diabetes Care"},{"issue":"1","key":"9602_CR42","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1210\/jc.87.1.144","volume":"87","author":"J H\u0159eb\u00ed\u010dek","year":"2002","unstructured":"H\u0159eb\u00ed\u010dek J, Janout V, Malin\u010d\u00edkov\u00e1 J, Hor\u00e1kov\u00e1 D, \u010c\u00ed\u017eek L. Detection of IR by simple quantitative insulin sensitivity check index QUICKI for epidemiological assessment and prevention. J Clin Endocrinol Metab. 2002;87(1):144\u20137.","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"9602_CR43","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1210\/jcem.85.7.6661","volume":"85","author":"A Katz","year":"2000","unstructured":"Katz A, Nambi SS, Mather K, Baron AD, Follmann D, Sullivan G, et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab. 2000;85(7):2402\u201310.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"9602_CR44","doi-asserted-by":"publisher","first-page":"295","DOI":"10.2337\/diacare.23.3.295","volume":"23","author":"M Stumvoll","year":"2000","unstructured":"Stumvoll M, Mitrakou A, Pimenta W, Jenssen T, Yki-J\u00e4rvinen H, Haeften T, et al. Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. Diabetes Care. 2000;23(3):295\u2013301.","journal-title":"Diabetes Care"},{"key":"9602_CR45","unstructured":"Houssay B. The role of the hypophysis in carbohydrate metabolism and in diabetes. Nobel Lecture December 12, 1947."},{"issue":"3","key":"9602_CR46","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1159\/000497214","volume":"108","author":"M Hage","year":"2019","unstructured":"Hage M, Kamenick\u00fd P, Chanson P. Growth hormone response to oral glucose load: from normal to pathological conditions. Neuroendocrinology. 2019;108(3):244\u201355.","journal-title":"Neuroendocrinology."},{"issue":"3","key":"9602_CR47","doi-asserted-by":"publisher","first-page":"E405","DOI":"10.1152\/ajpendo.00423.2003","volume":"287","author":"J Liu","year":"2004","unstructured":"Liu J, Coschigano KT, Robertson K, Lipsett M, Guo Y, Kopchick JJ, et al. Disruption of growth hormone receptor gene causes diminished pancreatic islet size and increased insulin sensitivity in mice. Am J Physiol Endocrinol Metab. 2004;287(3):E405\u201313.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"1","key":"9602_CR48","doi-asserted-by":"publisher","first-page":"S52","DOI":"10.1016\/S0168-8227(11)70014-6","volume":"93","author":"G Dimitriadis","year":"2011","unstructured":"Dimitriadis G, Mitrou P, Lambadiari V, Maratou E, Raptis SA. Insulin effects in muscle and adipose tissue. Diabetes Res Clin Pract. 2011;93(1):S52\u20139.","journal-title":"Diabetes Res Clin Pract"},{"issue":"4","key":"9602_CR49","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s00125-003-1074-z","volume":"46","author":"M Cnop","year":"2003","unstructured":"Cnop M, Havel P, Utzschneider K, Carr D, Sinha M, Boyko E, et al. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia. 2003;46(4):459\u201369.","journal-title":"Diabetologia."},{"issue":"6","key":"9602_CR50","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.2337\/dc12-1235","volume":"36","author":"K Kodama","year":"2013","unstructured":"Kodama K, Tojjar D, Yamada S, Toda K, Patel CJ, Butte A. Ethnic differences in the relationship between insulin sensitivity and insulin response: a systematic review and meta-analysis. Diabetes Care. 2013;36(6):1789\u201396.","journal-title":"Diabetes Care"},{"issue":"6","key":"9602_CR51","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.3390\/nu5062019","volume":"5","author":"P Patel","year":"2013","unstructured":"Patel P, Abate N. Body fat distribution and insulin resistance. Nutrients. 2013;5(6):2019\u201327.","journal-title":"Nutrients."},{"issue":"9","key":"9602_CR52","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/S2213-8587(19)30076-2","volume":"7","author":"R Taylor","year":"2019","unstructured":"Taylor R, Al-Mrabeh A, Sattar N. Understanding the mechanisms of reversal of type 2 diabetes. Lancet Diabetes Endocrinol. 2019;7(9):726\u201336.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"2","key":"9602_CR53","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1172\/JCI10583","volume":"106","author":"G Shulman","year":"2000","unstructured":"Shulman G. Cellular mechanisms of insulin resistance. J Clin Invest. 2000;106(2):171\u20136.","journal-title":"J Clin Invest"},{"issue":"12","key":"9602_CR54","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.2337\/diab.37.12.1595","volume":"37","author":"G Reaven","year":"1988","unstructured":"Reaven G. Role of insulin resistance in human disease. Diabetes. 1988;37(12):1595\u2013607.","journal-title":"Diabetes."},{"issue":"1","key":"9602_CR55","doi-asserted-by":"publisher","first-page":"108086","DOI":"10.1016\/j.diabres.2020.108086","volume":"162","author":"P Saeedi","year":"2020","unstructured":"Saeedi P, Salpea P, Karuranga S, Petersohn I, Malanda B, Gregg E, et al. Mortality attributable to diabetes in 20-79 years old adults, 2019 estimates: results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract. 2020;162(1):108086.","journal-title":"Diabetes Res Clin Pract"},{"issue":"8","key":"9602_CR56","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.10456","volume":"2","author":"N Wiebe","year":"2019","unstructured":"Wiebe N, Stenvinkel P, Tonelli M. Associations of chronic inflammation, insulin resistance, and severe obesity with mortality, myocardial infarction, cancer, and chronic pulmonary disease. JAMA Netw Open. 2019;2(8):e1910456.","journal-title":"JAMA Netw Open"},{"issue":"6","key":"9602_CR57","first-page":"717","volume":"19","author":"A Giustina","year":"1998","unstructured":"Giustina A, Veldhuis JD. Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human. Endocr Rev. 1998;19(6):717\u201397.","journal-title":"Endocr Rev"},{"issue":"1","key":"9602_CR58","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.ghir.2015.06.001","volume":"28","author":"MJ Waters","year":"2016","unstructured":"Waters MJ. The growth hormone receptor. Growth Hormon IGF Res. 2016;28(1):6\u201310.","journal-title":"Growth Hormon IGF Res"},{"issue":"1","key":"9602_CR59","doi-asserted-by":"publisher","first-page":"R31","DOI":"10.1530\/EJE-13-0532","volume":"170","author":"M Andersen","year":"2013","unstructured":"Andersen M. Management of endocrine disease: GH excess: diagnosis and medical therapy. Eur J Endocrinol. 2013;170(1):R31\u201341.","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"9602_CR60","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1210\/endo-15-6-511","volume":"15","author":"B Houssay","year":"1931","unstructured":"Houssay B, Biasotti A. The hypophysis, carbohydrate metabolism and diabetes. Endocrinology. 1931;15(6):511\u201323.","journal-title":"Endocrinology."},{"issue":"8","key":"9602_CR61","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.2337\/diabetes.50.8.1891","volume":"50","author":"A Takano","year":"2001","unstructured":"Takano A, Haruta T, Iwata M, Usui I, Uno T, Kawahara J, et al. Growth hormone induces cellular insulin resistance by uncoupling phosphatidylinositol 3-kinase and its downstream signals in 3T3-L1 adipocytes. Diabetes. 2001;50(8):1891\u2013900.","journal-title":"Diabetes."},{"key":"9602_CR62","doi-asserted-by":"crossref","unstructured":"Lee P, Durham S, Martinez V, Vasconez O, Powell DR y Guevara-Aguirre J. Kinetics of insulin-like growth factor (IGF) and IGF-binding protein responses to a single dose of growth hormone. J Clin Endocrinol Metab 1997; 82(7):2266\u20132274.","DOI":"10.1210\/jc.82.7.2266"},{"issue":"1","key":"9602_CR63","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s00125-014-3397-3","volume":"58","author":"J Guevara-Aguirre","year":"2015","unstructured":"Guevara-Aguirre J, Rosenbloom AL. Obesity, diabetes and cancer: insight into the relationship from a cohort with growth hormone receptor deficiency. Diabetologia. 2015;58(1):37\u201342.","journal-title":"Diabetologia."},{"issue":"5","key":"9602_CR64","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.physbeh.2003.10.018","volume":"80","author":"BA Kinney-Forshee","year":"2004","unstructured":"Kinney-Forshee BA, Kinney NE, Steger RW, Bartke A. Could a deficiency in growth hormone signaling be beneficial to the aging brain? Physiol Behav. 2004;80(5):589\u201394.","journal-title":"Physiol Behav"},{"issue":"6","key":"9602_CR65","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.mad.2010.06.004","volume":"131","author":"S Sharma","year":"2010","unstructured":"Sharma S, Haselton J, Rakoczy S, Branshaw S, Brown-Borg HM. Spatial memory is enhanced in long-living Ames dwarf mice and maintained following kainic acid induced neurodegeneration. Mech Ageing Dev. 2010;131(6):422\u201335.","journal-title":"Mech Ageing Dev"},{"issue":"5","key":"9602_CR66","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/S0031-9384(01)00423-1","volume":"72","author":"BA Kinney","year":"2001","unstructured":"Kinney BA, Coschigano KT, Kopchick JJ, Steger RW, Bartke A. Evidence that age-induced decline in memory retention is delayed in growth hormone resistant GH-R-KO -Laron- mice. Physiol Behav. 2001;72(5):653\u201360.","journal-title":"Physiol Behav"},{"issue":"7","key":"9602_CR67","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1523\/JNEUROSCI.1929-16.2016","volume":"37","author":"K Nashiro","year":"2017","unstructured":"Nashiro K, Guevara-Aguirre J, Braskie M, Hafzalla G, Velasco R, Balasubramanian P, et al. Brain structure and function associated with younger adults in growth hormone receptor-deficient humans. J Neurosci. 2017;37(7):1696\u2013707.","journal-title":"J Neurosci"},{"issue":"1","key":"9602_CR68","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.ghir.2020.02.004","volume":"51","author":"J Guevara-Aguirre","year":"2020","unstructured":"Guevara-Aguirre J, Teran E, Lescano D, Guevara A, Guevara C, Longo V, et al. Growth hormone receptor deficiency in humans associates to obesity, increased body fat percentage, a healthy brain and a coordinated insulin sensitivity. Growth Horm IGF Res. 2020;51(1):58\u201364.","journal-title":"Growth Horm IGF Res"},{"issue":"10","key":"9602_CR69","doi-asserted-by":"publisher","first-page":"3642","DOI":"10.1158\/1078-0432.CCR-04-1868","volume":"11","author":"S Otake","year":"2005","unstructured":"Otake S, Takeda H, Suzuki Y, Fukui T, Watanabe S, Ishihama K, et al. Association of visceral fat accumulation and plasma adiponectin with colorectal adenoma: evidence for participation of insulin resistance. Clin Cancer Res. 2005;11(10):3642\u20136.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"9602_CR70","first-page":"80","volume":"15","author":"JP Thissen","year":"1994","unstructured":"Thissen JP, Ketelslegers JM, Underwood LE. Nutritional regulation of the insulin-like growth factors. Endocr Rev. 1994;15(1):80\u2013101.","journal-title":"Endocr Rev"},{"issue":"3","key":"9602_CR71","doi-asserted-by":"publisher","first-page":"s867","DOI":"10.1093\/ajcn\/86.3.867S","volume":"86","author":"I Hsu","year":"2007","unstructured":"Hsu I, Kim S, Kabir M, Bergman R. Metabolic syndrome, hyperinsulinemia, and cancer. Am J Clin Nutr. 2007;86(3):s867\u201371.","journal-title":"Am J Clin Nutr"},{"issue":"1","key":"9602_CR72","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1530\/ERC-12-0324","volume":"20","author":"S Djiogue","year":"2013","unstructured":"Djiogue S, Nwabo Kamdje A, Vecchio L, Kipanyula M, Farahna M, Aldebasi Y, et al. Insulin resistance and cancer: the role of insulin and IGFs. Endocr Relat Cancer. 2013;20(1):R1\u2013R17.","journal-title":"Endocr Relat Cancer"},{"issue":"2","key":"9602_CR73","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1093\/oxfordjournals.epirev.a000809","volume":"23","author":"D Gunnell","year":"2001","unstructured":"Gunnell D, Okasha M, Smith GD, Oliver SE, Sandhu J, Holly JM. Height, leg length, and cancer risk: a systematic review. Epidemiol Rev. 2001;23(2):313\u201342.","journal-title":"Epidemiol Rev"},{"key":"9602_CR74","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.semcancer.2015.12.005","volume":"37\u201338","author":"F Ribezzo","year":"2016","unstructured":"Ribezzo F, Shiloh Y, Schumacher B. Systemic DNA damage responses in aging and diseases. Semin Cancer Biol. 2016;37\u201338:26\u201335.","journal-title":"Semin Cancer Biol"},{"issue":"4","key":"9602_CR75","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1097\/MED.0b013e328363183a","volume":"20","author":"JK Perry","year":"2013","unstructured":"Perry JK, Liu D, Wu Z, Zhu T, Lobie E. Growth hormone and cancer: an update on progress. Curr Opin Endocrinol Diabetes Obes. 2013;20(4):307\u201313.","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"4","key":"9602_CR76","doi-asserted-by":"publisher","first-page":"R147","DOI":"10.1530\/EJE-16-0178","volume":"175","author":"C Boguszewski","year":"2016","unstructured":"Boguszewski C, Ayuk J. Acromegaly and cancer: an old debate revisited. Eur J Endocrinol. 2016;175(4):R147\u201356.","journal-title":"Eur J Endocrinol"},{"key":"9602_CR77","first-page":"209","volume-title":"Endocrinology: adult and pediatric","author":"MS Acromegaly","year":"2016","unstructured":"Acromegaly MS. Endocrinology: adult and pediatric. New York: Elsevier Saunders; 2016. p. 209\u201326."},{"issue":"1","key":"9602_CR78","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/j.1365-2265.1994.tb03789.x","volume":"41","author":"C Rajasoorya","year":"1994","unstructured":"Rajasoorya C, Holdaway IM, Wrightson P, Scott DJ, Ibbertson HK. Determinants of clinical outcome and survival in acromegaly. Clin Endocrinol. 1994;41(1):95\u2013102.","journal-title":"Clin Endocrinol"},{"issue":"1","key":"9602_CR79","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1210\/er.2002-0022","volume":"25","author":"A Colao","year":"2004","unstructured":"Colao A, Ferone D, Marzullo P, Lombardi G. Systemic complications of acromegaly: epidemiology, pathogenesis, and management. Endocr Rev. 2004;25(1):102\u201352.","journal-title":"Endocr Rev"},{"issue":"2","key":"9602_CR80","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s10552-013-0317-7","volume":"25","author":"S Wir\u00e9n","year":"2014","unstructured":"Wir\u00e9n S, H\u00e4ggstr\u00f6m C, Ulmer H, Manjer J, Bj\u00f8rge T, Nagel G, et al. Pooled cohort study on height and risk of cancer and cancer death. Cancer Causes Control. 2014;25(2):151\u20139.","journal-title":"Cancer Causes Control"},{"issue":"10","key":"9602_CR81","doi-asserted-by":"publisher","first-page":"4536","DOI":"10.1210\/en.2007-0513","volume":"148","author":"Q Shen","year":"2007","unstructured":"Shen Q, Lantvit D, Lin Q, Lim Y, Christov K, Wang Z, et al. Advanced rat mammary cancers are growth hormone dependent. Endocrinology. 2007;148(10):4536\u201344.","journal-title":"Endocrinology."},{"issue":"1","key":"9602_CR82","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1093\/carcin\/bgl138","volume":"28","author":"X Zhang","year":"2007","unstructured":"Zhang X, Mehta R, Lantvit D, Coschigano K, Kopchick J, Green J, et al. Inhibition of estrogen-independent mammary carcinogenesis by disruption of growth hormone signaling. Carcinogenesis. 2007;28(1):143\u201350.","journal-title":"Carcinogenesis."},{"issue":"1","key":"9602_CR83","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1038\/ncb1737","volume":"10","author":"S Rowlinson","year":"2008","unstructured":"Rowlinson S, Yoshizato H, Barclay J, Brooks A, Behncken S, Kerr L, et al. An agonist-induced conformational change in the growth hormone receptor determines the choice of signaling pathway. Nat Cell Biol. 2008;10(1):740\u20137.","journal-title":"Nat Cell Biol"},{"key":"9602_CR84","doi-asserted-by":"crossref","unstructured":"Valentinis B, Baserga R. IGF-I receptor signalling in transformation and differentiation. Mol Pathol. 54(3):133\u20137.","DOI":"10.1136\/mp.54.3.133"},{"issue":"33","key":"9602_CR85","doi-asserted-by":"publisher","first-page":"25451","DOI":"10.1074\/jbc.M002271200","volume":"275","author":"B Valentinis","year":"2000","unstructured":"Valentinis B, Navarro M, Zanocco-Marani T, Edmonds P, McCormick J, Morrione A, et al. Insulin receptor substrate-1, p79S6K, and cell size in transformation and differentiation of hematopoietic cells. J Biol Chem. 2000;275(33):25451\u20139.","journal-title":"J Biol Chem"},{"issue":"1","key":"9602_CR86","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","volume":"100","author":"D Hanahan","year":"2000","unstructured":"Hanahan D, Weinberg R. The hallmarks of cancer. Cell. 2000;100(1):57\u201370.","journal-title":"Cell."},{"issue":"7","key":"9602_CR87","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1593\/neo.09310","volume":"11","author":"N Linnerth","year":"2009","unstructured":"Linnerth N, Siwicky M, Campbell C, Watson K, Petrik J, Whitsett J, et al. Type I insulin-like growth factor receptor induces pulmonary tumorigenesis. Neoplasia. 2009;11(7):672\u201382.","journal-title":"Neoplasia."},{"issue":"2","key":"9602_CR88","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1002\/jcp.10207","volume":"194","author":"L Mauro","year":"2003","unstructured":"Mauro L, Salerno M, Morelli C, Boterberg T, Bracke M, Surmacz E. Role of the IGF-I receptor in the regulation of cell-cell adhesion: implications in cancer development and progression. J Cell Physiol. 2003;194(2):108\u201316.","journal-title":"J Cell Physiol"},{"issue":"2","key":"9602_CR89","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.canlet.2007.07.019","volume":"257","author":"S Maor","year":"2007","unstructured":"Maor S, Yosepovich A, Papa M, Yarden R, Mayer D, Friedman E, et al. Elevated insulin-like growth factor-I receptor (IGF-IR) levels in primary breast tumors associated with BRCA1 mutations. Cancer Lett. 2007;257(2):236\u201343.","journal-title":"Cancer Lett"},{"issue":"5","key":"9602_CR90","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1093\/gerona\/glp017","volume":"64","author":"Y Ikeno","year":"2009","unstructured":"Ikeno Y, Hubbard G, Lee S, Cortez L, Lew C, Webb C, et al. Reduced incidence and delayed occurrence of fatal neoplastic diseases in growth hormone receptor\/binding protein knockout mice. J Gerontol. 2009;64(5):522\u20139.","journal-title":"J Gerontol"},{"issue":"2","key":"9602_CR91","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.pharmthera.2013.12.004","volume":"142","author":"J Polivka","year":"2014","unstructured":"Polivka J, Janku F. Molecular targets for cancer therapy in the PI3K\/AKT\/mTOR pathway. Pharmacol Ther. 2014;142(2):164\u201375.","journal-title":"Pharmacol Ther"},{"issue":"1","key":"9602_CR92","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/nature04869","volume":"441","author":"R Shaw","year":"2006","unstructured":"Shaw R, Cantley L. Ras, PI(3)K and mTOR signalling controls tumour cell growth. Nature. 2006;441(1):424\u201330.","journal-title":"Nature."},{"issue":"11","key":"9602_CR93","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1016\/j.bbamcr.2011.01.007","volume":"1813","author":"H Huang","year":"2011","unstructured":"Huang H, Tindall D. Regulation of FoxO protein stability via ubiquitination and proteasome degradation. Biochem Biophys Acta. 2011;1813(11):1961\u20134.","journal-title":"Biochem Biophys Acta"},{"key":"9602_CR94","doi-asserted-by":"crossref","unstructured":"McCubrey J, Steelman L, Chappell W, Abrams S, Montalto G, Cervello M, et al. Mutations and deregulation of Ras\/Raf\/MEK\/ERK and PI3K\/PTEN\/Akt\/mTOR cascades which alter therapy response. Oncotarget. 3(9):954\u201387.","DOI":"10.18632\/oncotarget.652"},{"issue":"4","key":"9602_CR95","doi-asserted-by":"publisher","first-page":"4241","DOI":"10.18632\/oncotarget.6648","volume":"7","author":"K Yi","year":"2016","unstructured":"Yi K, Lauring J. Recurrent AKT mutations in human cancers: functional consequences and effects on drug sensitivity. Oncotarget. 2016;7(4):4241\u201351.","journal-title":"Oncotarget."},{"issue":"10","key":"9602_CR96","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1517\/14728220903201702","volume":"13","author":"I Bruchim","year":"2009","unstructured":"Bruchim I, Attias Z, Werner H. Targeting the IGF1 axis in cancer proliferation. Expert Opin Ther Targets. 2009;13(10):1179\u201392.","journal-title":"Expert Opin Ther Targets"},{"issue":"24","key":"9602_CR97","doi-asserted-by":"publisher","first-page":"10238","DOI":"10.1158\/0008-5472.CAN-08-2755","volume":"68","author":"J Law","year":"2008","unstructured":"Law J, Habibi G, Hu K, Masoudi H, Wang M, Stratford A, et al. Phosphorylated insulin-like growth factor-i\/insulin receptor is present in all breast cancer subtypes and is related to poor survival. Cancer Res. 2008;68(24):10238\u201346.","journal-title":"Cancer Res"},{"issue":"42","key":"9602_CR98","doi-asserted-by":"publisher","first-page":"39684","DOI":"10.1074\/jbc.M202766200","volume":"277","author":"G Pandini","year":"2002","unstructured":"Pandini G, Frasca F, Mineo R, Sciacca L, Vigneri R, Belfiore A. Insulin\/insulin-like growth factor I hybrid receptors have different biological characteristics depending on the insulin receptor isoform involved. J Biol Chem. 2002;277(42):39684\u201395.","journal-title":"J Biol Chem"},{"issue":"1","key":"9602_CR99","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1159\/000430819","volume":"103","author":"J Dal","year":"2016","unstructured":"Dal J, List E, J\u00f8rgensen J, Berryman D. Glucose and fat metabolism in acromegaly: from mice models to patient care. Neuroendocrinology. 2016;103(1):96\u2013105.","journal-title":"Neuroendocrinology."},{"issue":"2","key":"9602_CR100","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1530\/EC-14-0021","volume":"3","author":"A Dreval","year":"2014","unstructured":"Dreval A, Trigolosova I, Miskinova I, Kovalyova Y, Tishenina R, Barsukov I, et al. Prevalence of diabetes mellitus in patients with acromegaly. Endocr Connect. 2014;3(2):93\u20138.","journal-title":"Endocr Connect"},{"issue":"9","key":"9602_CR101","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1590\/S0004-27302008000900004","volume":"52","author":"D Fedrizzi","year":"2008","unstructured":"Fedrizzi D, Czepielewski M. Cardiovascular disturbances in acromegaly. Arq Bras Endocrinol Metab. 2008;52(9):1416\u201329.","journal-title":"Arq Bras Endocrinol Metab"},{"issue":"6","key":"9602_CR102","doi-asserted-by":"publisher","first-page":"E6","DOI":"10.1016\/S2213-8587(18)30150-5","volume":"6","author":"J Pearson-Stuttard","year":"2017","unstructured":"Pearson-Stuttard J, Zhou B, Kontis V, Bentham J, Gunter M, Ezzati M. Worldwide burden of cancer attributable to diabetes and high body-mass index: a comparative risk assessment. Lancet Diabetes Endocrinol. 2017;6(6):E6\u2013e15.","journal-title":"Lancet Diabetes Endocrinol"}],"container-title":["Reviews in Endocrine and Metabolic Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11154-020-09602-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11154-020-09602-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11154-020-09602-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T15:58:44Z","timestamp":1696867124000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11154-020-09602-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,12]]},"references-count":102,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["9602"],"URL":"https:\/\/doi.org\/10.1007\/s11154-020-09602-4","relation":{},"ISSN":["1389-9155","1573-2606"],"issn-type":[{"value":"1389-9155","type":"print"},{"value":"1573-2606","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,12]]},"assertion":[{"value":"1 October 2020","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors have no conflicts of interest, nor they have competing interests to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable for this manuscript since no data from research subjects was needed for this review. All author\u2019s referenced papers have individual ethics approval by official IRBs.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable for this manuscript since no research subjects were necessary for this review. All author\u2019s referenced papers have informed consents signed by subjects participating in each corresponding study protocol.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Listed authors actively participated in developing this manuscript; hence, fully consent on the publication of each and all parts of it.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Microsoft Word was used.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}}]}}